Related references
Note: Only part of the references are listed.Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer
Jillian Brechbiel et al.
CANCER TREATMENT REVIEWS (2014)
New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: Targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia
Eric C. Hales et al.
CELLULAR SIGNALLING (2014)
Three-dimensional structure of human γ-secretase
Peilong Lu et al.
NATURE (2014)
A Phase I Trial of MK-2206 in Children with Refractory Malignancies: A Children's Oncology Group Study
Maryam Fouladi et al.
PEDIATRIC BLOOD & CANCER (2014)
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
Ying Chen et al.
PLOS ONE (2014)
EFEMP1 induces gamma-secretase/Notch-mediated temozolomide resistance in glioblastoma
Lotte Hiddingh et al.
ONCOTARGET (2014)
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
Giulio Fiaschetti et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Inhibition of Notch signaling in combination with paclitaxel reduces platinum-resistant ovarian tumor growth
Jolijn W. Groeneweg et al.
FRONTIERS IN ONCOLOGY (2014)
Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures
Karina Kristoffersen et al.
CANCER BIOLOGY & THERAPY (2013)
Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
Sivaraman Natarajan et al.
CANCER RESEARCH (2013)
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2013)
Combination therapy using Notch and Akt inhibitors is effective for suppressing invasion but not proliferation in glioma cells
Rihua Jin et al.
NEUROSCIENCE LETTERS (2013)
The MEK/ERK Pathway Promotes NOTCH Signalling in Pancreatic Cancer Cells
Isabelle Tremblay et al.
PLOS ONE (2013)
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Genome-Wide Analysis of N1ICD/RBPJ Targets In Vivo Reveals Direct Transcriptional Regulation of Wnt, SHH, and Hippo Pathway Effectors by Notch1
Yaochen Li et al.
STEM CELLS (2012)
Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Determination of the γ-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS)
Feng Bai et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma
Yaming Qu et al.
ONCOLOGY REPORTS (2010)
gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Pedro J. Real et al.
NATURE MEDICINE (2009)
Shortening the timeline of pediatric phase I trials: The rolling six design
Jeffrey M. Skolnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway
Tao Wang et al.
CELLULAR SIGNALLING (2007)
Phase I study of everolimus in pediatric patients with refractory solid tumors
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hes1 and Hes5 regulate the development of the cranial and spinal nerve systems
J Hatakeyama et al.
DEVELOPMENTAL NEUROSCIENCE (2006)
Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression
K Balint et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Radial glia cells are candidate stem cells of ependymoma
MD Taylor et al.
CANCER CELL (2005)
Meningioma transcript profiles reveal deregulated notch signaling pathway
IC Cuevas et al.
CANCER RESEARCH (2005)
Notch1 and Notch2 have opposite effects on embryonal brain tumor growth
X Fan et al.
CANCER RESEARCH (2004)
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway
G Tonon et al.
NATURE GENETICS (2003)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
TN Ignatova et al.
GLIA (2002)
Share Paper
